Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Davita Inc. (DVA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Davita Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 927066.
Total stock buying since 2015: $2,015,440.
Total stock sales since 2015: $1,222,348,434.
Total stock option exercises since 2015: $531,428,875.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 1,658,480 | $199,939,714 | 52,144 | $5,680,045 |
| 2025 | 0 | $0 | 3,192,918 | $460,502,426 | 10,484 | $990,016 |
| 2024 | 0 | $0 | 290,712 | $42,977,081 | 2,018,018 | $132,428,141 |
| 2023 | 0 | $0 | 55,207 | $5,475,417 | 1,020,834 | $67,869,618 |
| 2022 | 20,000 | $1,554,000 | 3,020 | $305,559 | 117,477 | $7,702,297 |
| 2021 | 0 | $0 | 80,980 | $10,238,754 | 356,302 | $25,530,394 |
| 2020 | 5,500 | $461,440 | 4,425,442 | $389,120,261 | 386,947 | $28,444,993 |
| 2018 | 0 | $0 | 6,679 | $493,995 | 1,356,023 | $81,355,328 |
| 2017 | 0 | $0 | 159,566 | $10,778,033 | 1,326,600 | $71,260,061 |
| 2016 | 0 | $0 | 361,766 | $26,495,390 | 1,019,617 | $46,481,259 |
| 2015 | 0 | $0 | 973,560 | $76,021,804 | 1,497,875 | $63,686,723 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-15 | Zumwalt Leanne M (Grp VP, Purch & Public Affairs) | Sale | 1,800 | 66.32 | 119,377 |
| 2017-05-09 | Berg Charles | Sale | 8,414 | 65.80 | 553,607 |
| 2017-05-09 | Berg Charles | Option Ex | 24,000 | 42.47 | 1,019,160 |
| 2017-05-04 | Valine Roger | Sale | 12,994 | 66.21 | 860,371 |
| 2017-05-04 | Valine Roger | Option Ex | 36,000 | 42.47 | 1,528,740 |
| 2017-05-04 | Roper William L | Sale | 12,994 | 65.89 | 856,148 |
| 2017-05-04 | Roper William L | Option Ex | 36,000 | 42.47 | 1,528,740 |
| 2017-05-04 | Nehra John M | Option Ex | 36,000 | 42.47 | 1,528,740 |
| 2017-02-23 | Zumwalt Leanne M (Grp VP, Purch & Public Affairs) | Sale | 807 | 68.72 | 55,460 |
| 2016-11-30 | Rodriguez Javier (CEO-Kidney Care) | Option Ex | 80,000 | 36.96 | 2,956,800 |
| 2016-08-09 | Staffieri Michael David (COO, Kidney Care) | Sale | 20,262 | 73.09 | 1,480,888 |
| 2016-08-09 | Staffieri Michael David (COO, Kidney Care) | Option Ex | 40,000 | 37.19 | 1,487,400 |
| 2016-07-11 | Jiganti Jeanine Marie (Chief Compliance Officer) | Sale | 1,291 | 78.51 | 101,358 |
| 2016-07-11 | Jiganti Jeanine Marie (Chief Compliance Officer) | Option Ex | 938 | 48.68 | 45,661 |
| 2016-07-01 | Jiganti Jeanine Marie (Chief Compliance Officer) | Sale | 4,620 | 77.45 | 357,809 |
| 2016-07-01 | Jiganti Jeanine Marie (Chief Compliance Officer) | Option Ex | 15,512 | 53.59 | 831,334 |
| 2016-05-27 | Grauer Peter T | Option Ex | 36,000 | 41.47 | 1,492,740 |
| 2016-05-25 | Arway Pamela M | Sale | 10,824 | 77.16 | 835,212 |
| 2016-05-25 | Arway Pamela M | Option Ex | 24,000 | 42.47 | 1,019,160 |
| 2016-05-23 | Hilger James K (Interim CFO and CAO) | Sale | 3,416 | 76.79 | 262,307 |
| 2016-05-23 | Hilger James K (Interim CFO and CAO) | Option Ex | 12,000 | 55.34 | 664,080 |
| 2016-05-20 | Thiry Kent J (Chairman and CEO) | Sale | 32,880 | 77.00 | 2,531,595 |
| 2016-05-17 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Sale | 17,700 | 77.35 | 1,369,112 |
| 2016-05-17 | Zumwalt Leanne M (Grp VP, Purch & Public Affairs) | Sale | 538 | 77.08 | 41,469 |
| 2016-05-16 | Staffieri Michael David (COO, Kidney Care) | Sale | 4,934 | 75.69 | 373,444 |
| 2016-05-16 | Rodriguez Javier (CEO-Kidney Care) | Sale | 36,466 | 75.44 | 2,751,104 |
| 2016-05-16 | Hilger James K (Interim CFO and CAO) | Sale | 3,983 | 75.59 | 301,074 |
| 2016-05-12 | Valine Roger | Sale | 8,220 | 76.34 | 627,531 |
| 2016-05-12 | Valine Roger | Option Ex | 18,000 | 41.47 | 746,370 |
| 2016-05-10 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Sale | 40,048 | 76.25 | 3,053,660 |
| 2016-05-10 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Option Ex | 166,250 | 57.14 | 9,499,525 |
| 2016-05-06 | Nehra John M | Sale | 16,314 | 75.56 | 1,232,767 |
| 2016-05-06 | Nehra John M | Option Ex | 36,000 | 41.47 | 1,492,740 |
| 2016-04-11 | Rodriguez Javier (CEO-Kidney Care) | Sale | 89,912 | 73.51 | 6,609,071 |
| 2016-04-11 | Rodriguez Javier (CEO-Kidney Care) | Option Ex | 216,667 | 43.35 | 9,392,514 |
| 2016-03-21 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Sale | 13,455 | 72.12 | 970,320 |
| 2016-03-21 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Option Ex | 56,250 | 55.34 | 3,112,875 |
| 2016-02-29 | Arway Pamela M | Sale | 9,026 | 66.00 | 595,716 |
| 2016-02-29 | Arway Pamela M | Option Ex | 24,000 | 41.47 | 995,160 |
| 2016-02-23 | Zumwalt Leanne M (Grp VP, Purch & Public Affairs) | Sale | 14,587 | 64.25 | 937,273 |
| 2016-02-23 | Zumwalt Leanne M (Grp VP, Purch & Public Affairs) | Option Ex | 44,000 | 43.35 | 1,907,400 |
| 2016-02-16 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Sale | 33,290 | 61.99 | 2,063,680 |
| 2016-02-16 | Kogod Dennis (Pres, HCP & CEO, DVA Int.) | Option Ex | 250,000 | 43.35 | 10,837,500 |
| 2015-12-17 | Mildenberger Laura (Chief People Officer) | Sale | 1,440 | 68.14 | 98,124 |
| 2015-12-17 | Mildenberger Laura (Chief People Officer) | Option Ex | 9,550 | 49.34 | 471,244 |
| 2015-11-09 | Thiry Kent J (Chairman and CEO) | Sale | 300,000 | 75.61 | 22,681,500 |
| 2015-11-09 | Thiry Kent J (Chairman and CEO) | Option Ex | 1,000,000 | 43.35 | 43,350,000 |
| 2015-09-22 | Rivera Kim M (Chief Legal Officer) | Sale | 40,037 | 75.60 | 3,026,797 |
| 2015-09-22 | Rivera Kim M (Chief Legal Officer) | Option Ex | 95,000 | 49.34 | 4,687,775 |
| 2015-08-17 | Davidson Carol Anthony | Sale | 4,038 | 79.93 | 322,765 |
| 2015-08-17 | Davidson Carol Anthony | Option Ex | 7,500 | 37.05 | 277,912 |
| 2015-08-10 | Jiganti Jeanine Marie (Chief Compliance Officer) | Sale | 1,311 | 81.37 | 106,680 |
| 2015-08-10 | Jiganti Jeanine Marie (Chief Compliance Officer) | Option Ex | 938 | 48.68 | 45,661 |
| 2015-08-06 | Berg Charles | Sale | 11,636 | 81.01 | 942,585 |
| 2015-08-06 | Berg Charles | Option Ex | 24,000 | 41.47 | 995,160 |
| 2015-06-05 | Grauer Peter T (Director) | Option Ex | 36,000 | 31.32 | 1,127,520 |
| 2015-06-04 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 83.23 | 1,306,742 |
| 2015-06-03 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 83.77 | 1,315,189 |
| 2015-05-28 | Staffieri Michael David (COO, Kidney Care) | Sale | 9,050 | 84.07 | 760,806 |
| 2015-05-28 | Staffieri Michael David (COO, Kidney Care) | Option Ex | 35,000 | 41.51 | 1,452,675 |
| 2015-05-20 | Mildenberger Laura (Chief People Ofcr, Kidney Care) | Sale | 9,579 | 83.15 | 796,493 |
| 2015-05-20 | Mildenberger Laura (Chief People Ofcr, Kidney Care) | Option Ex | 20,000 | 43.35 | 867,000 |
| 2015-05-19 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 83.22 | 1,306,585 |
| 2015-05-18 | Staffieri Michael David (COO, Kidney Care) | Sale | 2,047 | 82.03 | 167,911 |
| 2015-05-18 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 82.25 | 1,291,246 |
| 2015-05-18 | Mildenberger Laura (Chief People Ofcr, Kidney Care) | Sale | 461 | 82.75 | 38,148 |
| 2015-05-18 | Kogod Dennis (COO, HealthCare Partners) | Sale | 36,466 | 82.50 | 3,008,445 |
| 2015-05-18 | Hilger James K (Interim CFO & CAO) | Sale | 3,983 | 82.10 | 327,012 |
| 2015-05-18 | Zumwalt Leanne M (Grp VP Purch & Public Affairs) | Sale | 538 | 82.49 | 44,378 |
| 2015-05-15 | Rivera Kim M (Chief Legal Officer) | Sale | 3,241 | 81.89 | 265,405 |
| 2015-05-15 | Rodriguez Javier (CEO, Kidney Care) | Sale | 36,466 | 81.50 | 2,972,015 |
| 2015-05-11 | Jiganti Jeanine Marie (Chief Compliance Officer) | Sale | 2,481 | 81.92 | 203,250 |
| 2015-05-11 | Jiganti Jeanine Marie (Chief Compliance Officer) | Option Ex | 4,687 | 48.68 | 228,163 |
| 2015-05-11 | Hilger James K (Interim CFO & CAO) | Sale | 8,267 | 82.00 | 677,894 |
| 2015-05-11 | Hilger James K (Interim CFO & CAO) | Option Ex | 17,500 | 43.35 | 758,625 |
| 2015-05-11 | Nehra John M (Director) | Sale | 12,278 | 81.85 | 1,004,978 |
| 2015-05-11 | Nehra John M (Director) | Option Ex | 36,000 | 31.32 | 1,127,520 |
| 2015-04-27 | Rodriguez Javier (CEO, Kidney Care) | Sale | 20,946 | 84.57 | 1,771,403 |
| 2015-04-27 | Rodriguez Javier (CEO, Kidney Care) | Option Ex | 43,333 | 43.35 | 1,878,485 |
| 2015-04-21 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 82.94 | 1,302,110 |
| 2015-04-20 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 81.87 | 1,285,374 |
| 2015-04-07 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 82.15 | 1,289,802 |
| 2015-04-06 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 81.49 | 1,279,455 |
| 2015-03-27 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 81.41 | 1,278,105 |
| 2015-03-26 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 80.95 | 1,270,930 |
| 2015-03-20 | Diaz Paul J (Director) | Option Ex | 24,000 | 65.08 | 1,561,920 |
| 2015-03-12 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 79.42 | 1,246,846 |
| 2015-03-12 | Rodriguez Javier (CEO, Kidney Care) | Sale | 2,803 | 79.40 | 222,558 |
| 2015-03-12 | Rodriguez Javier (CEO, Kidney Care) | Option Ex | 4,667 | 31.70 | 147,943 |
| 2015-03-11 | Margolis Robert J (Co-Chairman of the Board) | Sale | 91,674 | 79.18 | 7,258,563 |
| 2015-03-10 | Mildenberger Laura (Chief People Ofcr, Kidney Care) | Sale | 1,199 | 77.75 | 93,222 |
| 2015-03-10 | Mildenberger Laura (Chief People Ofcr, Kidney Care) | Option Ex | 2,700 | 43.35 | 117,045 |
| 2015-02-27 | Margolis Robert J (Co-Chairman of the Board) | Sale | 10,500 | 74.41 | 781,315 |
| 2015-02-26 | Margolis Robert J (Co-Chairman of the Board) | Sale | 10,500 | 74.17 | 778,732 |
| 2015-02-24 | Staffieri Michael David (COO, Kidney Care) | Sale | 19,712 | 73.58 | 1,450,468 |
| 2015-02-19 | Margolis Robert J (Co-Chairman of the Board) | Sale | 10,500 | 73.12 | 767,760 |
| 2015-02-18 | Margolis Robert J (Co-Chairman of the Board) | Sale | 10,500 | 73.12 | 767,760 |
| 2015-01-30 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 75.47 | 1,184,926 |
| 2015-01-29 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 75.49 | 1,185,255 |
| 2015-01-23 | Staffieri Michael David (COO, Kidney Care) | Sale | 21,869 | 76.05 | 1,663,224 |
| 2015-01-23 | Staffieri Michael David (COO, Kidney Care) | Option Ex | 40,000 | 34.52 | 1,380,600 |
| 2015-01-16 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 74.96 | 1,176,903 |
| 2015-01-15 | Margolis Robert J (Co-Chairman of the Board) | Sale | 15,700 | 74.88 | 1,175,568 |
| 2015-01-08 | Rivera Kim M (Chief Legal Officer) | Sale | 1,111 | 75.10 | 83,436 |
| 2015-01-02 | Staffieri Michael David (COO, Kidney Care) | Sale | 53,427 | 75.68 | 4,043,141 |
| 2015-01-02 | Staffieri Michael David (COO, Kidney Care) | Option Ex | 97,000 | 33.11 | 3,211,475 |
Insider trading activities including stock purchases, stock sales, and option exercises of DVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Davita Inc. (symbol DVA, CIK number 927066) see the Securities and Exchange Commission (SEC) website.